Literature DB >> 19841359

Late results of the surgical treatment of 125 patients with short-segment Barrett esophagus.

Attila Csendes1, Italo Braghetto, Patricio Burdiles, Gladys Smok, Ana Henríquez, Ana Maria Burgos.   

Abstract

HYPOTHESIS: The results of surgical treatment of patients with long-segment Barrett esophagus (BE) have been extensively reported. However, few publications refer to the results of surgery 5 years after the fact among patients with short-segment BE. This study aimed to determine the late results of 3 surgical procedures in patients with short-segment BE by subjective and objective measurements.
DESIGN: Prospective, nonrandomized study starting on March 1, 1987, and ending on December 31, 2005.
SETTING: A prospective, descriptive study of a group of patients. PATIENTS: A total of 125 patients with short-segment BE underwent 3 operations in different periods: duodenal switch plus highly selective vagotomy and antireflux technique in 31 patients, vagotomy plus partial gastrectomy and Roux-en-Y loop with antireflux surgery in 58 patients, and laparoscopic Nissen fundoplication in 36 patients. MAIN OUTCOME MEASURES: Late subjective and objective outcomes of the 3 different surgical procedures.
RESULTS: No operative mortality and only 2 postoperative complications (1.6%) occurred. The regression from intestinal metaplasia to cardiac or oxyntocardiac mucosa occurred in 60.8% to 65.4% of the patients, at a mean time of 39 to 56 months after surgery. Visick grading showed Visick grade I or II in 86.3% to 100.0% of the patients. No progression to low- or high-grade dysplasia or adenocarcinoma occurred.
CONCLUSIONS: On the basis of these results, laparoscopic Nissen fundoplication seems to be the surgical option for patients with short-segment BE because it is less invasive, has fewer side effects, and produces good results in the long-term follow-up.

Entities:  

Mesh:

Year:  2009        PMID: 19841359     DOI: 10.1001/archsurg.2009.83

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  6 in total

Review 1.  Vertical gastrectomy and gastric bypass in Roux-en-Y induce postoperative gastroesophageal reflux disease?

Authors:  Paulo Afonso Nunes Nassif; Osvaldo Malafaia; Jurandir Marcondes Ribas-Filho; Nicolau Gregori Czeczko; Rodrigo Ferreira Garcia; Bruno Luiz Ariede
Journal:  Arq Bras Cir Dig       Date:  2014

2.  Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett's esophagus: a prospective study.

Authors:  Italo Braghetto; Owen Korn; Attila Csendes; Luis Gutiérrez; Héctor Valladares; Max Chacon
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

3.  Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy.

Authors:  Giovanni Zaninotto; Paola Parente; Renato Salvador; Fabio Farinati; Chiara Tieppo; Nicola Passuello; Lisa Zanatta; Matteo Fassan; Francesco Cavallin; Mario Costantini; Claudia Mescoli; Giorgio Battaglia; Alberto Ruol; Ermanno Ancona; Massimo Rugge
Journal:  J Gastrointest Surg       Date:  2011-11-16       Impact factor: 3.452

Review 4.  Effect of medical and surgical treatment of Barrett's metaplasia.

Authors:  Eelco B Wassenaar; Brant K Oelschlager
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

5.  The patterns of reflux can affect regression of non-dysplastic and low-grade dysplastic Barrett's esophagus after medical and surgical treatment: a prospective case-control study.

Authors:  Salvatore Tolone; Paolo Limongelli; Marco Romano; Alessandro Federico; Giovanni Docimo; Roberto Ruggiero; Luigi Brusciano; Gianmattia Del Genio; Ludovico Docimo
Journal:  Surg Endosc       Date:  2014-07-17       Impact factor: 4.584

6.  Antireflux Surgery and Barrett's Esophagus: Myth or Reality?

Authors:  Fernando A M Herbella; Francisco Schlottmann; Marco G Patti
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.